Precision Medicine in Lung, Trauma, and Benign Chest Wall Disease.

This article explores the evolution and application of precision medicine within thoracic care, emphasizing its potential to enhance diagnosis, treatment, and prognosis by integrating genetic, environmental, sociocultural, and technological data. Key areas include the management of benign lung diseases-such as differentiating benign from malignant nodules and treating interstitial lung diseases-along with thoracic trauma and chest wall disorders. Despite promising advancements, challenges like data integration, infrastructural needs, and multidisciplinary collaboration remain. The article underscores that as these hurdles are addressed, precision medicine is poised to become a cornerstone of personalized thoracic care, ultimately improving outcomes and patient participation.